BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 7.05% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 6.81% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.83% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 4.35% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 4.23% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.74% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.67% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.36% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.09% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.01% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.96% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.94% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.79% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.71% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.63% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.45% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.24% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.10% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.97% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 1.91% |